Allianz Asset Management GmbH boosted its position in shares of Orthopediatrics Corp (NASDAQ:KIDS) by 2.9% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 137,068 shares of the company’s stock after acquiring an additional 3,833 shares during the quarter. Allianz Asset Management GmbH owned about 0.93% of Orthopediatrics worth $5,346,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of KIDS. Conestoga Capital Advisors LLC lifted its holdings in shares of Orthopediatrics by 4.4% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 10,395 shares of the company’s stock valued at $405,000 after buying an additional 440 shares during the period. JPMorgan Chase & Co. grew its position in shares of Orthopediatrics by 1.4% in the second quarter. JPMorgan Chase & Co. now owns 34,418 shares of the company’s stock valued at $1,326,000 after purchasing an additional 465 shares in the last quarter. Rhumbline Advisers lifted its holdings in Orthopediatrics by 6.6% in the first quarter. Rhumbline Advisers now owns 9,350 shares of the company’s stock valued at $414,000 after acquiring an additional 580 shares during the last quarter. Aperio Group LLC acquired a new position in Orthopediatrics in the second quarter valued at approximately $39,000. Finally, BNP Paribas Arbitrage SA lifted its holdings in Orthopediatrics by 83,150.0% in the first quarter. BNP Paribas Arbitrage SA now owns 1,665 shares of the company’s stock valued at $74,000 after acquiring an additional 1,663 shares during the last quarter. 48.16% of the stock is owned by institutional investors.
Shares of KIDS opened at $36.93 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.75 and a current ratio of 2.53. The company has a market capitalization of $531.55 million, a price-to-earnings ratio of -38.47 and a beta of 0.19. Orthopediatrics Corp has a fifty-two week low of $25.11 and a fifty-two week high of $47.82. The firm has a 50-day simple moving average of $32.82 and a 200-day simple moving average of $38.27.
Orthopediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.14) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.05). Orthopediatrics had a negative net margin of 15.77% and a negative return on equity of 12.92%. The firm had revenue of $18.20 million during the quarter, compared to analyst estimates of $18.44 million. During the same quarter in the previous year, the business earned ($0.21) EPS. Orthopediatrics’s revenue for the quarter was up 20.5% on a year-over-year basis. Equities research analysts forecast that Orthopediatrics Corp will post -0.82 EPS for the current year.
A number of research analysts have commented on the company. BidaskClub upgraded Orthopediatrics from a “sell” rating to a “hold” rating in a research note on Wednesday, September 4th. Needham & Company LLC initiated coverage on Orthopediatrics in a research report on Wednesday, June 19th. They set a “buy” rating and a $53.00 price objective on the stock. Zacks Investment Research lowered Orthopediatrics from a “buy” rating to a “hold” rating in a research report on Tuesday, August 13th. Finally, ValuEngine lowered Orthopediatrics from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $44.25.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.